Disclosures/Conflicts of interest The authors whose names are listed immediately below certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest) in the subject matter or materials discussed in this article
By linking genomic variation, functional traits, and environmental context, we generate data that strengthen pathogen surveillance, support risk-based decision-making, and inform regulatory science
FDA Approval: In June 2021, the FDA approved semaglutide as a weight loss treatment for individuals with a body mass index (BMI) of 27 and more, including those with a BMI of 30 and higher, especially when linked to weight-related health problems
How do I know if I should switch medications instead of alternating
Understanding how semaglutide units convert to milligrams eliminates confusion during dose escalation